文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

奥密克戎 BA.4/BA.5 逃避由 BA.1 感染引起的中和抗体免疫。

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.

机构信息

Africa Health Research Institute, Durban, South Africa.

School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

出版信息

Nat Commun. 2022 Aug 10;13(1):4686. doi: 10.1038/s41467-022-32396-9.


DOI:10.1038/s41467-022-32396-9
PMID:35948557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9364294/
Abstract

SARS-CoV-2 Omicron (B.1.1.529) BA.4 and BA.5 sub-lineages, first detected in South Africa, have changes relative to Omicron BA.1 including substitutions in the spike receptor binding domain. Here we isolated live BA.4 and BA.5 viruses and measured BA.4/BA.5 neutralization elicited by BA.1 infection either in the absence or presence of previous vaccination as well as from vaccination without BA.1 infection. In BA.1-infected unvaccinated individuals, neutralization relative to BA.1 declines 7.6-fold for BA.4 and 7.5-fold for BA.5. In vaccinated individuals with subsequent BA.1 infection, neutralization relative to BA.1 decreases 3.2-fold for BA.4 and 2.6-fold for BA.5. The fold-drop versus ancestral virus neutralization in this group is 4.0-fold for BA.1, 12.9-fold for BA.4, and 10.3-fold for BA.5. In contrast, BA.4/BA.5 escape is similar to BA.1 in the absence of BA.1 elicited immunity: fold-drop relative to ancestral virus neutralization is 19.8-fold for BA.1, 19.6-fold for BA.4, and 20.9-fold for BA.5. These results show considerable escape of BA.4/BA.5 from BA.1 elicited immunity which is moderated with vaccination and may indicate that BA.4/BA.5 may have the strongest selective advantage in evading neutralization relative to BA.1 in unvaccinated, BA.1 infected individuals.

摘要

SARS-CoV-2 奥密克戎(B.1.1.529)BA.4 和 BA.5 亚谱系最初在南非被发现,与奥密克戎 BA.1 相比有变化,包括刺突受体结合域的取代。在这里,我们分离了活的 BA.4 和 BA.5 病毒,并测量了 BA.1 感染后未接种疫苗或接种疫苗但未感染 BA.1 时,BA.4/BA.5 中和反应。在未接种疫苗的 BA.1 感染个体中,相对于 BA.1,BA.4 的中和作用下降了 7.6 倍,BA.5 下降了 7.5 倍。在随后感染 BA.1 的接种个体中,相对于 BA.1,BA.4 的中和作用下降了 3.2 倍,BA.5 下降了 2.6 倍。与原始病毒相比,该组中 BA.1 的中和作用下降了 4.0 倍,BA.4 下降了 12.9 倍,BA.5 下降了 10.3 倍。相比之下,在没有 BA.1 诱导免疫的情况下,BA.4/BA.5 逃逸与 BA.1 相似:相对于原始病毒的中和作用下降了 19.8 倍,BA.4 下降了 19.6 倍,BA.5 下降了 20.9 倍。这些结果表明,BA.4/BA.5 从 BA.1 诱导的免疫中逃逸的程度很大,而接种疫苗可以减轻这种逃逸,这可能表明,与接种疫苗、BA.1 感染的个体相比,BA.4/BA.5 在逃避中和方面可能具有最强的选择优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/4109c547fd39/41467_2022_32396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/488fc9faa27a/41467_2022_32396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/433e809c01f9/41467_2022_32396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/4109c547fd39/41467_2022_32396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/488fc9faa27a/41467_2022_32396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/433e809c01f9/41467_2022_32396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8aa/9365829/4109c547fd39/41467_2022_32396_Fig3_HTML.jpg

相似文献

[1]
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.

Nat Commun. 2022-8-10

[2]
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.

Int J Mol Sci. 2022-7-12

[3]
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.

Microbiol Spectr. 2023-6-15

[4]
Omicron infection enhances Delta antibody immunity in vaccinated persons.

Nature. 2022-7

[5]
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.

Nature. 2022-8

[6]
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.

Front Immunol. 2022

[7]
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.

Cell Host Microbe. 2022-8-10

[8]
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

J Virol. 2024-7-23

[9]
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.

Cell Host Microbe. 2022-11-9

[10]
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants.

Microbiol Spectr. 2025-1-7

引用本文的文献

[1]
Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.

Proc Natl Acad Sci U S A. 2025-9-2

[2]
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort.

Sci Rep. 2025-7-9

[3]
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort.

Vaccines (Basel). 2025-5-24

[4]
SARS-CoV-2 spike protein: structure, viral entry and variants.

Nat Rev Microbiol. 2025-5-6

[5]
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses.

Npj Viruses. 2024-11-21

[6]
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults.

Vaccines (Basel). 2025-2-28

[7]
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.

Vaccines (Basel). 2025-2-27

[8]
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity.

Front Immunol. 2025-3-21

[9]
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination.

Front Immunol. 2025-1-22

[10]
The consequences of SARS-CoV-2 within-host persistence.

Nat Rev Microbiol. 2025-5

本文引用的文献

[1]
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.

Nat Methods. 2023-4

[2]
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.

Nature. 2022-8

[3]
Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients.

Front Immunol. 2022

[4]
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.

Nat Med. 2022-9

[5]
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.

N Engl J Med. 2022-7-7

[6]
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.

Nature. 2022-8

[7]
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies.

Lancet Infect Dis. 2022-7

[8]
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.

Immunity. 2022-7-12

[9]
Omicron infection enhances Delta antibody immunity in vaccinated persons.

Nature. 2022-7

[10]
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.

Cell Host Microbe. 2022-6-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索